Microarray Company OGT Now Offering Targeted Sequencing Services | GenomeWeb

By Monica Heger

Microarray company Oxford Gene Technologies is moving into the next-gen sequencing space, offering targeted capture and sequencing services on Illumina's HiSeq, Life Technologies' SOLiD, and Roche's 454 GS FLX.

OGT does not currently own any sequencing machines, but is looking to purchase one by the end of the year. For the time being, it is contracting out its sequencing to academic and commercial partners while doing the capture and bioinformatics in house.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.